Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases

Epidemiology and Infection

Volumn 121, Issue 2, 1998, Pages 335-347

  Iribarren, C ^a   Jacobs Jr , D R ^b   Sidney, S ^a   Claxton, A J ^b   Feingold, K R ^c  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; CHOLESTEROL BLOOD LEVEL; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NERVOUS SYSTEM; RISK FACTOR; SEPTICEMIA; SEX DIFFERENCE; UNITED STATES; URINARY TRACT INFECTION; UROGENITAL TRACT INFECTION; VIRUS INFECTION;

ADULT; AGE FACTORS; AGED; CHOLESTEROL; COHORT STUDIES; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS;

EID: 0031755469     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268898001435     Document Type: Article

References (58)

1. Jacobs DR Jr, Blackburn H, Higgins M, et al. Report of the conference on low blood cholesterol:mortality associations. Circulation 1992; 86: 1046-60.
2. Neaton JD, Blackburn H, Jacobs DR Jr, et al. for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol level and mortality. Findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 1992; 152: 1490-500.
3. Davey Smith G, Shipley MJ, Marmot MG, Rose G. Plasma cholesterol concentration and mortality: the Whitehall Study. JAMA 1992; 267: 70-6.
4. Iribarren C, Reed DM, Burchfiel CM, Dwyer JH. Serum total cholesterol and mortality: confounding and risk modification in Japanese - American men. JAMA 1995; 273: 1926-32.
5. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study. Ann Intern Med 1979; 90: 85-91.
6. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure and mortality: implications from a cohort of 361662 men. Lancet 1986; i: 933-6.
7. Hulley SB, Walsh JMB, Newman TB. Health policy on blood cholesterol. Time to change directions. Circulation 1992; 86: 1026-9.
8. Feingold KR, Funk JL, Moser AH, Shigenaga JK, Rapp JH, Grunfeld C. Role of circulating lipoproteins in protection from endotoxin toxicity. Infect Immun 1995; 63: 2041-6.
9. Neaton JD, Wentworth DN. Serum cholesterol, blood pressure, and risk of death from AIDS. AIDS 1997; 11: 929-30.
10. Claxton AJ, Jacobs Jr DR, Iribarren C, Welles S, Sidney S, Feingold K. The association between serum total cholesterol and HIV infection in a high risk cohort of young men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 51-7.
11. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992; 82: 703-10.
12. Collen MF, ed. Multiphasic health testing services. New York: John Wiley & Sons, 1978.
13. Abell LL, Levy BB, Brodie BB, Kendall FE. Simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952; 195: 357-66.
14. Iribarren C, Jacobs DR Jr, Sidney S, Claxton AJ, Gross MD, Sadler M, Blackburn H. Serum total cholesterol and risk of hospitalization and death from respiratory disease in a large cohort. Int J Epidemiol 1997; 26: 1191-202.
15. International Classification of Diseases, 9th revision, 3rd edn. Clinical modification, volumes 1, 2, 3. Los Angeles, CA: Practice Management Information Corporation (PMI), 1989.
16. Arellano M, Peterson G, Petitti DB, Smith R. The California automated mortality linkage system. Am J Pub Health 1984; 74: 1324-30.
17. Cox DR. Regression models and life tables. J R Statist Soc 1972; 34: 187-202.
18. Higgins M, Keller JB. Cholesterol, coronary heart disease, and total mortality in middle-aged and elderly men and women in Tecumseh. Ann Epidemiol 1992; 2: 69-76.
19. Harris T, Feldman JJ, Kleinman JC, Ettinger WH, Makuc DM, Schatzkin AG. The low cholesterol-mortality association in a national cohort. J Clin Epidemiol 1992; 45: 595-601.
20. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, Levine DM. Serum cholesterol in young men and subsequent cardiovascular disease. N Eng J Med 1993; 328: 313-8.
21. Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992; 41 (Suppl 2): 97-101.
22. Grunfeld C, Feingold KR. Regulation of lipid metabolism by cytokines during host defense. Nutrition 1996; 12 (Suppl): S24-6.
23. Hardardottir I, Grunfeld C, Feingold KR. Effects of endotoxin on lipid metabolism. Biochem Soc Trans 1995; 23: 1013-8.
24. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80.
25. Van Lenten BJ, Fogelman AM, Haberland ME, Edwards PA. The role of lipoproteins and receptormediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1986; 83: 2704-8.
26. Read TE, Grunfeld C, Kumwenda ZL, et al. Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med 1995; 182: 267-72.
27. Harris HW, Grunfeld C, Feingold KR, et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993; 91: 1028-34.
28. Fisher MH, Kaplan EL, Wannamaker LW. Cholesterol inhibition of streptolysin O toxicity for myocardial cells in tissue culture. Proc Soc Exp Biol Med 1981; 168: 233-7.
29. Kaplan EL, Wannamaker LW. Suppression of the antistreptolysin O response by cholesterol and by lipid extracts of rabbit skin. J Exp Med 1976: 144: 754-67.
30. Sernatiger J, Hoffman A, Hardman D, Kane JP, Levy JA. Neutralization of mouse xenotropic virus by lipoproteins involves binding to the virions. J Gen Virol 1988; 69: 2657-61.
31. Huemer HP, Menzel HJ, Potratz D, Brake B, Falke D, Utermann G, Dierich MP. Herpes simplex virus binds to human serum lipoprotein. Intervirol 1988; 29: 68-76.
32. Hager KM, Hajduk SL. Mechanism of resistance of African trypanosomes to cytotoxic human HDL. Nature 1997; 385: 823-6.
33. Kayden HJ, Traber MG. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 1993; 34: 343-58.
34. Clevidence BA, Bieri JG. Association of carotenoids with human plasma lipoproteins. Methods Enzymol 1993; 214: 33-46.
35. Semba RD, Vitamin A, immunity, and infection. Clin Infect Dis 1994; 19: 489-99.
36. Watson RR. Immunological enhancement by fat-soluble vitamins, minerals, and trace metals: a factor in cancer prevention. Cancer Detect Prev 1986; 9: 67-77.
37. Moriguchi S, Jackson JC, Watson RR. Effects of retinoids on human lymphocyte functions in vitro. Hum Toxicol 1985; 4: 365-78.
38. Lim TS, Putt N, Safranski D, Chung C, Watson RR. Effect of vitamin E on cell-mediated immune responses and serum corticosterone in young and maturing mice. Immunology 1981; 44: 289-95.
39. Meydani SN, Meydani M, Verdon CP, Blumberg JP, Hayes KC. Vitamin E supplementation suppresses prostaglandin E2 synthesis and enhances immune response of aged mice. Mech Ageing Dev 1986; 34: 191-201.
40. Meydani SN, Barklund PM, Liu S, et al. Effect of vitamin E supplementation on immune responsiveness of healthy elderly subjects. Am J Clin Nutr 1990; 52: 557-63.
41. Siguel E. A new relationship between total/high density lipoprotein cholesterol and polyunsaturated fatty acids. Lipids 1996; 31: S51-6.
42. Derr J, Kris-Etherton PM, Pearson TA, Seligson FH. The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins. II. The plasma total and low-density lipoprotein cholesterol response of individual fatty acids. Metabolism 1993; 42: 130-4.
43. Matsuo N, Osada K, Kodama T, Lim BO, Nakao A, Yamada K, Sugano M. Effects of gamma-linolenic acid and its positional isomer pinolenic acid on immune parameters of brown-Norway rats. Prostaglandins Leukot Essent Fatty Acids 1996; 55: 223-9.
44. Knapp HR, Melly MA. Bactericidal effects of polyunsaturated fatty acids. J Infect Dis 1986; 154: 84-94.
45. Prasad AS. Discovery of human zinc deficiency and studies in an experimental human model. Am J Clin Nutr 1991; 53: 403-12.
46. Prasad AS, Meftah S, Abdallah J, Kaplan J, Brewer GJ, Bach JF, Dardenne M. Serum thymulin in human zinc deficiency. J Clin Invest 1988; 82: 1202-10.
47. Evans RB. Physical and biochemical characteristics of homosexual men. J Consult Clin Psychol 1972; 39: 140-7.
48. Iribarren C, Jacobs Jr. DR, Slattery ML, Liu K, Sidney S, Hebert BJ, Roseman J. Epidemiology of low plasma cholesterol concentration in young adults. Prev Med 1997; 26: 495-507.
49. Beisel WR, Fiser RH Jr. Lipid metabolism during infectious illness. Am J Clin Nutr 1970; 23: 1069-79.
50. Beisel WR. Impact of infectious disease upon fat metabolism and immune functions. Cancer Res 1981; 41: 3797-8.
51. Alvarez C, Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 1986; 32: 142-5.
52. Lees RS, Fiser RH Jr, Beisel WR, Bartelloni PJ. Effects of an experimental viral infection on plasma lipid and lipoprotein metabolism. Metabolism 1972; 21: 825-33.
53. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988; 37: 859-65.
54. Jacobs DR Jr., Hebert B, Schreiner PJ, Sidney S, Iribarren C, Hulley S. Reduced cholesterol is associated with minor recent illness: the CARDIA study. Am J Epidemiol 1997; 146: 558-64.
55. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein, Immunol Today 1994; 15: 81-8.
56. Ettinger WH, Varma VK, Sorci-Thomas M, et al. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. Arteriosclerosis Throm 1994; 14: 8-13.
57. Allison DB, Heo M, Flanders DW, Faith MS, Williamson DF. Examination of 'early mortality exclusion' as an approach to control for confounding by occult disease in epidemiological studies of mortality risk factors. Am J Epidemiol 1997; 146: 672-80.
58. Iribarren C, Sharp DS, Burchfiel CM, Dwyer JH. Association of serum total cholesterol with coronary disease and all-cause mortality: multivariate correction for bias due to measurement error. Am J Epidemiol 1996; 143: 463-71.